Botanical species · safety record

Embelia tsjeriam-cottam

The EFSA Compendium of Botanicals holds 5 constituent measurements and 2 adverse-effect records for Embelia tsjeriam-cottam. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Embelia tsjeriam-cottam (Roem. & Schult.) A.DC.

5Constituent measurements
2Safety records
4Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Embelin3
  • Alkaloids1
  • Tannins1

Plant parts

  • Fruit unspecified5
  • Leaves2

Preparations

  • Solvent extraction5
  • Fresh2

Target tissues

  • Neurologic: central nervous system2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsFruit unspecifiedSolvent extractionPhytochemical screeningNo resolvable identifier
EmbelinFruit unspecifiedSolvent extraction≥ 1.09 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
EmbelinFruit unspecifiedSolvent extraction1.6 PercentUnspecifiedNo resolvable identifier
EmbelinFruit unspecifiedSolvent extraction≤ 5.21 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
TanninsFruit unspecifiedSolvent extractionPhytochemical screeningNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
Not statedNeurologic: central nervous systemLeavesFreshSheep (as animal)Case reportResolve DOI
Not statedNeurologic: central nervous systemLeavesFreshGoat (as animal)Case reportResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Dar, Umair Ikram., Saleem, Farooq., Touqeer, Saad. Antimicrobial and antioxidant activity of Embelia robusta: a common adulterant in black pepper. Pakistan journal of pharmaceutical research, 2016, vol. 2, no. 2, p. 136-141.
  2. Pandey, A. K., Ojha, Vijayalakshmi. Estimation of Embelin in Embelia tsjeriam-cottam Fruits by HPLC to Standardize Harvesting Time . Indian journal of pharmaceutical sciences, 2011, vol. 73, no. 2, p. 216-U.
  3. Bhatia, Harpreet., Manhas, R. K., Kumar, Kewal., Magotra, Rani. Traditional knowledge on poisonous plants of Udhampur district of Jammu and Kashmir, India . Journal of ethnopharmacology, 2014, vol. 152, no. 1, p. 207-216. DOI
  4. Krishna, S., Varma, B. S. Active principles of Embelia robusta, Roxb., Myrsine semiserrata, Wall, and M. capitellata, Wall. Forest research inst. dehra dun, (india) forest bull., 1941, vol. 102, p. 3 pp.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue